
Fertility Supplement Market Report 2026
Global Outlook – By Product (Tablets, Capsules, Powders, Liquids, Soft Gels, Other Products), By Ingredient Type (Natural, Synthetic Or Blend Of Natural And Synthetic), By Distribution Channel (Over-The-Counter, Prescribed, Other Distribution Channels), By End Use (Men, Women) - Market Size, Trends, And Global Forecast 2026-2035
Fertility Supplement Market Overview
• Fertility Supplement market size has reached to $1.93 billion in 2025 • Expected to grow to $2.8 billion in 2030 at a compound annual growth rate (CAGR) of 7.6% • Growth Driver: Rising Infertility Prevalence And The Growing Demand For Fertility Support • Market Trend: Advancements In Personalized Fertility Solutions For Women's Health • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Fertility Supplement Market?
Fertility supplements refer to dietary products designed to support reproductive health and improve fertility. They often contain vitamins, minerals, herbs, and other natural compounds that promote hormonal balance, egg quality, sperm health, and overall reproductive function. These supplements are commonly used by individuals trying to conceive or manage fertility-related issues. The main products of fertility supplements include tablets, capsules, powders, liquids, soft gels, and others. Tablets are solid, compressed forms of fertility supplements that are easy to dose and commonly used. It is made of both natural and synthetic or a blend of natural and synthetic ingredients and is distributed through various channels such as over-the-counter, prescribed, and others. It is used by both men and women.
What Is The Fertility Supplement Market Size and Share 2026?
The fertility supplement market size has grown strongly in recent years. It will grow from $1.93 billion in 2025 to $2.09 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to increased awareness of reproductive nutrition, growth in dietary supplement consumption, expansion of health retail stores, rising infertility concerns, availability of otc fertility supplements.What Is The Fertility Supplement Market Growth Forecast?
The fertility supplement market size is expected to see strong growth in the next few years. It will grow to $2.8 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to innovation in fertility-focused formulations, growth in preventive reproductive health, increasing use of personalized supplements, expansion of digital health platforms, rising consumer trust in nutraceuticals. Major trends in the forecast period include rising use of nutritional supplements for fertility support, growing preference for natural and herbal ingredients, increased demand from both male and female consumers, expansion of over-the-counter fertility products, growth of online supplement sales channels.Global Fertility Supplement Market Segmentation
1) By Product: Tablets, Capsules, Powders, Liquids, Soft Gels, Other Products 2) By Ingredient Type: Natural, Synthetic Or Blend Of Natural And Synthetic 3) By Distribution Channel: Over-The-Counter, Prescribed, Other Distribution Channels 4) By End Use: Men, Women Subsegments: 1) By Tablets: Standard Tablets, Effervescent Tablets 2) By Capsules: Gelatin Capsules, Vegetarian Capsules 3) By Powders: Drink Mix Powders, Nutritional Powders 4) By Liquids: Oral Liquid Supplements, Liquid Drops 5) By Soft Gels: Standard Soft Gels, High-Absorption Soft Gels 6) By Other Products: Chewable Supplements, Gummy SupplementsWhat Is The Driver Of The Fertility Supplement Market?
The increasing prevalence of infertility is expected to propel the growth of the fertility supplement market going forward. Infertility is the inability to conceive after one year of regular, unprotected intercourse or the inability to carry a pregnancy to term. Increasing infertility is driven by factors such as delayed childbearing, lifestyle changes, environmental toxins, rising obesity, and higher stress levels. Fertility supplements are required for treating infertility, as they provide essential vitamins, minerals, and nutrients that support reproductive health, hormone balance, and overall fertility function. For instance, in April 2023, according to the World Health Organization (WHO), a Switzerland-based United Nations specialized agency responsible for global public health, approximately 17.5% of the global adult population, equivalent to about one in six individuals, are affected by infertility. Therefore, the increasing prevalence of infertility drives the growth of the fertility supplement industry.Key Players In The Global Fertility Supplement Market
Major companies operating in the fertility supplement market are GNC Holdings LLC, Orthomol Holding, Vitabiotics Ltd., Lenus Pharma GesmbH, Innovamed Ltd., AdvaCare Pharma, Theralogix LLC, Fairhaven Health LLC, Coast Science LLC, Bionova Inc., Extreme V Inc., Crown Fertility, Xena Bio Herbals Pvt. Ltd., Zenith Nutrition Co, Amitamin, Eu Natural Inc., Proxeed, Babystart Ltd., Needed Inc., Ritual, Premama Wellness Company, Pink StorkGlobal Fertility Supplement Market Trends and Insights
Major companies operating in the fertility supplement market are focusing on developing personalized products, such as natural fertility supplements, to offer a holistic approach to enhancing reproductive health using plant-based ingredients and essential nutrients, with fewer synthetic chemicals and potential side effects compared to conventional treatments. Natural fertility supplements are dietary products made from plant-based ingredients, vitamins, and minerals that aim to enhance reproductive health and improve fertility by supporting hormonal balance, egg quality, and overall reproductive function. For instance, in November 2024, Nestlé, a Switzerland-based health and wellness company, launched the Materna Pre and Materna Nausea solutions. The Materna range has expanded with two new products designed to support women’s fertility and alleviate common pregnancy-related symptoms, such as nausea and vomiting. By incorporating natural ginger and vitamin B6, the new Materna Nausea product is scientifically proven to reduce the severity of nausea and vomiting during pregnancy. This expansion reflects Materna’s commitment to providing women with tailored, science-based nutritional solutions that support them before conception, throughout pregnancy, and after childbirth, ultimately aiming to improve health outcomes for both mothers and their babies.What Are Latest Mergers And Acquisitions In The Fertility Supplement Market?
In March 2023, Sumitovant Biopharma Ltd., a US-based pharmaceutical company, acquired Myovant Sciences Ltd. for $1.7 billion. Through this acquisition, Sumitomo Pharma seeks to harness the combined expertise of Sumitovant and Myovant to expedite the development of innovative therapies. The integration aims to maximize the potential of ORGOVYX and MYFEMBREE, broaden the reach of differentiated treatments, and drive progress in ongoing clinical programs. Myovant Sciences Ltd. is a UK-based company that develops fertility supplements.Regional Outlook
North America was the largest region in the fertility supplement market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Fertility Supplement Market?
The fertility supplement market consists of sales of prenatal vitamins, ovulation support supplements, PCOS treatment supplements, and sperm health supplements. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Fertility Supplement Market Report 2026?
The fertility supplement market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the fertility supplement industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Fertility Supplement Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $2.09 billion |
| Revenue Forecast In 2035 | $2.8 billion |
| Growth Rate | CAGR of 7.9% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product, Ingredient Type, Distribution Channel, End Use |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | GNC Holdings LLC, Orthomol Holding, Vitabiotics Ltd., Lenus Pharma GesmbH, Innovamed Ltd., AdvaCare Pharma, Theralogix LLC, Fairhaven Health LLC, Coast Science LLC, Bionova Inc., Extreme V Inc., Crown Fertility, Xena Bio Herbals Pvt. Ltd., Zenith Nutrition Co, Amitamin, Eu Natural Inc., Proxeed, Babystart Ltd., Needed Inc., Ritual, Premama Wellness Company, Pink Stork |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
